Charles Schwab Investment Management Inc. increased its position in Ardent Health, Inc. (NYSE:ARDT - Free Report) by 100.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 57,255 shares of the company's stock after purchasing an additional 28,650 shares during the quarter. Charles Schwab Investment Management Inc.'s holdings in Ardent Health were worth $787,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of ARDT. Point72 Asia Singapore Pte. Ltd. bought a new position in Ardent Health in the fourth quarter worth approximately $27,000. Morse Asset Management Inc bought a new position in Ardent Health in the first quarter worth approximately $36,000. Deutsche Bank AG grew its stake in Ardent Health by 1,251.9% in the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock worth $49,000 after purchasing an additional 2,654 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new position in Ardent Health in the first quarter worth approximately $142,000. Finally, Beacon Capital Management LLC bought a new position in Ardent Health in the first quarter worth approximately $144,000.
Ardent Health Stock Up 2.5%
Shares of Ardent Health stock traded up $0.33 during trading on Friday, reaching $13.19. The company's stock had a trading volume of 278,081 shares, compared to its average volume of 283,294. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. The company has a market cap of $1.89 billion, a price-to-earnings ratio of 7.29, a P/E/G ratio of 5.82 and a beta of 0.29. Ardent Health, Inc. has a 1-year low of $10.10 and a 1-year high of $20.72. The company has a 50-day simple moving average of $12.34 and a two-hundred day simple moving average of $13.16.
Ardent Health (NYSE:ARDT - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.30 by $0.22. The firm had revenue of $1.65 billion during the quarter, compared to analysts' expectations of $1.54 billion. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, equities analysts forecast that Ardent Health, Inc. will post 1.23 earnings per share for the current year.
Wall Street Analysts Forecast Growth
ARDT has been the topic of several research analyst reports. Stephens reissued an "overweight" rating and issued a $21.00 price objective on shares of Ardent Health in a research note on Tuesday, May 20th. KeyCorp dropped their target price on Ardent Health from $24.00 to $20.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $21.00 target price on shares of Ardent Health in a research report on Thursday, May 15th. Wall Street Zen raised Ardent Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Finally, Bank of America cut Ardent Health from a "neutral" rating to an "underperform" rating and dropped their target price for the company from $15.50 to $14.60 in a research report on Wednesday, July 16th. Eight research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.56.
Read Our Latest Stock Report on ARDT
Ardent Health Company Profile
(
Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Further Reading
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
